Cidara Therapeutics Stock (NASDAQ: CDTX) stock price, news, charts, stock research, profile.
You can purchase shares of Cidara Therapeutics (NASDAQ:CDTX) through any online brokerage.
Other companies in Cidara Therapeutics’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Voyager Therapeutics (NASDAQ:VYGR), Monopar Therapeutics (NASDAQ:MNPR), Larimar Therapeutics (NASDAQ:LRMR) and Tango Therapeutics (NASDAQ:TNGX).
Cidara Therapeutics has a consensus price target of $32.20.
The stock price for Cidara Therapeutics (NASDAQ: CDTX) is $21.7 last updated February 21, 2025 at 6:49 AM EST.
There are no upcoming dividends for Cidara Therapeutics.
Cidara Therapeutics’s Q1 earnings are confirmed for Wednesday, May 14, 2025.
There is no upcoming split for Cidara Therapeutics.
Cidara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.